Analysts Set SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) PT at $70.83
Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Get Free Report) have received a consensus recommendation of “Buy” from the six brokerages that are covering the firm, Marketbeat Ratings reports. Six investment analysts have rated the stock with a buy rating. The average 1-year price objective among analysts that have issued a report on the stock […]
Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Get Free Report) have received a consensus recommendation of “Buy” from the six brokerages that are covering the firm, Marketbeat Ratings reports. Six investment analysts have rated the stock with a buy rating. The average 1-year price objective among analysts that have issued a report on the stock […]
